Acta Pharmaceutica Sinica B · 2021 · 22 citations · 34 references
PharmacyMolecular PharmaceuticsOncologyCancer PharmacologyGene DeliveryGene ExpressionCancer NanomedicineDna NanotechnologyEndosomal EscapeNanomedicineNanoparticle DesignNucleic Acid DeliveryConjugationDna NanocarriersDna NanomaterialsEndosomal Escape DesignEndosomal Escape EfficiencyEpidermal Growth Factor Receptor InhibitionEscapeTumor-targeted Drug Delivery
The functionality of DNA biomacromolecules has been widely excavated, as therapeutic drugs, carriers, and functionalized modification derivatives. In this study, we developed a series of DNA tetrahedron nanocages (Td), via synchronous conjugating different numbers of i-(X) and therapeutic siRNA on four vertexes of tetrahedral DNA nanocage ([email protected], a+b = 4). This i-motif-conjugated Td exhibited good endosomal escape behaviours in A549 tumor cells, and the escape efficiency was affected by the number of i-motif. Furthermore, the downregulating mRNA and protein expression level of epidermal growth factor receptor (EGFR) caused by this siRNA embedded Td were verified in A549 cells. The tumor growth inhibition efficiency of the [email protected] treated group in tumor-bearing mice was significantly higher than that of non-i-motif-conjugated [email protected] (3.14-fold) and free siRNA (3.63-fold). These results demonstrate a general strategy for endowing DNA nanostructures with endosomal escape behaviours to achieve effective in vivo gene delivery and therapy.
34
Russell P. Goodman, Richard M. Berry, Andrew J. Turberfield · Chemical Communications · 2004 · 506 citations
Acoustically Propelled Nanomotors for Intracellular siRNA Delivery
Berta Esteban‐Fernández de Ávila, Chava Angell, Fernando Soto et al. · ACS Nano · 2016 · 306 citations
DNA Nanostructure-Programmed Like-Charge Attraction at the Cell-Membrane Interface
Hong‐Ming Ding, Jiang Li, Nan Chen et al. · ACS Central Science · 2018 · 247 citations · Full text
Life Sciences, Biology, Biophysics +17